For the year ending 2025-12-31, ADTX made $3,195 in revenue. -$43,101,451 in net income. Net profit margin of -1349028.20%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Sales | 3,195 | 133,985 | ||
| Cost of goods sold | 2,927 | 627,474 | ||
| Gross profit (loss) | 268 | -493,489 | ||
| General and administrative expenses 0 and 33,071in stock-based compensation, respectively | 15,974,863 | 16,286,216 | ||
| Research and development 10,000 and 6,712,663 in stock-based compensation, respectively | 3,194,133 | 10,886,130 | ||
| Sales and marketing 473,311 and 0 in stock-based compensation, respectively | 401,996 | 197,863 | ||
| Total operating expenses | 19,570,992 | 27,370,209 | ||
| Net loss from operations | -19,570,724 | -27,863,698 | ||
| Interest expense | 681,156 | 4,188,725 | ||
| Interest income | 200,179 | 1,454 | ||
| Amortization of debt discount | 1,706,697 | 3,174,920 | ||
| Change in fair value of derivative liability | -14,515 | -414,501 | ||
| Change in fair value of evofem warrants | -2,806,983 | - | ||
| Impairment of evofem f-1 preferred stock | 23,766,209 | - | ||
| Bargain purchase gain from purchase of evofem convertible notes | -328,071 | - | ||
| Gain (loss) on note exchange agreement | - | -208,670 | ||
| Impairment of fixed assets | 412,005 | - | ||
| Total other expense | -23,216,319 | -7,156,360 | ||
| Net loss before income taxes | -42,787,043 | -35,020,058 | ||
| Net loss | -42,787,043 | -35,020,058 | ||
| Deemed dividends | -1,387,250 | -5,907,011 | ||
| Net loss attributable to non-controlling interest | -1,072,842 | -573,572 | ||
| Net loss attributable to aditxt, inc. & subsidiaries | -43,101,451 | -40,353,497 | ||
| Basic EPS | -1,153.83 | -3,062.51 | ||
| Diluted EPS | -1,153.83 | -3,062.51 | ||
| Basic Average Shares | 37,355 | 13,177 | ||
| Diluted Average Shares | 37,355 | 13,177 | ||
Aditxt, Inc. (ADTX)
Aditxt, Inc. (ADTX)